CVS Health (CVS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Economist Justin Wolfers dropped a number on the Prof G Markets podcast that should reorganize how you think about the 2026 economy.
CVS Health faced intense investor scrutiny in 2024 and 2025 amid efforts to recover from a downturn but has since turned things around. Q1 2026 results showed that the insurance business is exploding for CVS. CVS also posted other positive signs of growth, such as improved retail pharmacy market share.
Here is how CVS Health (CVS) and Align Technology (ALGN) have performed compared to their sector so far this year.
Despite some high-profile retreats by health insurers from Medicare Advantage, the privatized medical coverage for older adults continues to add health plan members and is now the choice of 55% of eligible beneficiaries, a new report shows.
The latest trading day saw CVS Health (CVS) settling at $95.93, representing a +1.17% change from its previous close.
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock?
CVS Health (CVS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.